MRX-I: Phase II started

MicuRx began a double-blind, U.S. Phase II trial to compare 800 mg oral

Read the full 137 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE